Total Assets Summary of Medistim ASA

Medistim ASA's latest annual total assets in 2023 was 505.71 Million NOK , up 4.78% from previous year.
Medistim ASA's latest quarterly total assets in 2024 Q3 was 491 Million NOK , up 2.97% from previous quarter.
Medistim ASA reported annual total assets of 482.65 Million NOK in 2022, up 19.69% from previous year.
Medistim ASA reported annual total assets of 403.24 Million NOK in 2021, up 16.61% from previous year.
Medistim ASA reported quarterly total assets of 491 Million NOK for 2024 Q3, up 2.97% from previous quarter.
Medistim ASA reported quarterly total assets of 476.85 Million NOK for 2024 Q2, down -9.75% from previous quarter.

Annual Total Assets Chart of Medistim ASA (2023 - 2004)

Historical Annual Total Assets of Medistim ASA (2023 - 2004)

Year	Total Assets	Total Assets Growth
2023	505.71 Million NOK	4.78%
2022	482.65 Million NOK	19.69%
2021	403.24 Million NOK	16.61%
2020	345.82 Million NOK	2.89%
2019	336.1 Million NOK	24.67%
2018	269.59 Million NOK	7.38%
2017	251.06 Million NOK	15.67%
2016	217.04 Million NOK	-0.63%
2015	218.43 Million NOK	7.35%
2014	203.48 Million NOK	20.84%
2013	168.39 Million NOK	10.88%
2012	151.86 Million NOK	1.5%
2011	149.62 Million NOK	2.52%
2010	145.94 Million NOK	0.22%
2009	145.62 Million NOK	0.17%
2008	145.38 Million NOK	12.88%
2007	128.79 Million NOK	8.09%
2006	119.14 Million NOK	40.18%
2005	84.99 Million NOK	14.57%
2004	74.18 Million NOK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	528.35 Million NOK	4.48%
2024 Q3	491 Million NOK	2.97%
2024 Q2	476.85 Million NOK	-9.75%
2023 Q3	474.89 Million NOK	7.46%
2023 Q1	499.54 Million NOK	3.5%
2023 Q2	441.93 Million NOK	-11.53%
2023 FY	505.71 Million NOK	4.78%
2023 Q4	505.71 Million NOK	6.49%
2022 Q2	397.64 Million NOK	-6.98%
2022 FY	482.65 Million NOK	19.69%
2022 Q3	432.42 Million NOK	8.75%
2022 Q4	482.65 Million NOK	11.62%
2022 Q1	427.49 Million NOK	6.01%
2021 Q3	362.58 Million NOK	9.19%
2021 Q2	332.07 Million NOK	-9.04%
2021 Q4	403.24 Million NOK	11.21%
2021 Q1	365.09 Million NOK	5.57%
2021 FY	403.24 Million NOK	16.61%
2020 Q1	363.08 Million NOK	8.02%
2020 Q2	368.27 Million NOK	1.43%
2020 Q3	394.75 Million NOK	7.19%
2020 Q4	345.82 Million NOK	-12.4%
2020 FY	345.82 Million NOK	2.89%
2019 Q2	258.7 Million NOK	-9.53%
2019 Q3	282.26 Million NOK	9.11%
2019 Q4	336.1 Million NOK	19.08%
2019 FY	336.1 Million NOK	24.67%
2019 Q1	285.95 Million NOK	6.07%
2018 Q1	252.73 Million NOK	0.67%
2018 Q4	269.59 Million NOK	15.3%
2018 Q2	217.06 Million NOK	-14.11%
2018 Q3	233.81 Million NOK	7.72%
2018 FY	269.59 Million NOK	7.38%
2017 FY	251.06 Million NOK	15.67%
2017 Q4	251.06 Million NOK	10.47%
2017 Q3	227.26 Million NOK	6.55%
2017 Q2	213.29 Million NOK	-6.56%
2017 Q1	228.25 Million NOK	5.16%
2016 Q3	206 Million NOK	5.4%
2016 FY	217.04 Million NOK	-0.63%
2016 Q2	195.45 Million NOK	-11.16%
2016 Q4	217.04 Million NOK	5.36%
2016 Q1	219.99 Million NOK	0.71%
2015 FY	218.43 Million NOK	7.35%
2015 Q1	205.6 Million NOK	1.04%
2015 Q2	238.22 Million NOK	15.86%
2015 Q3	200.99 Million NOK	-15.63%
2015 Q4	218.43 Million NOK	8.68%
2014 Q3	181.76 Million NOK	4.9%
2014 Q1	168.94 Million NOK	0.33%
2014 FY	203.48 Million NOK	20.84%
2014 Q4	203.48 Million NOK	11.95%
2014 Q2	173.27 Million NOK	2.56%
2013 Q4	168.39 Million NOK	6.94%
2013 Q2	154.34 Million NOK	0.44%
2013 Q1	153.66 Million NOK	1.18%
2013 FY	168.39 Million NOK	10.88%
2013 Q3	157.45 Million NOK	2.02%
2012 Q2	147.52 Million NOK	-3.88%
2012 Q1	153.48 Million NOK	2.58%
2012 Q3	148.59 Million NOK	0.73%
2012 FY	151.86 Million NOK	1.5%
2012 Q4	151.86 Million NOK	2.2%
2011 Q2	141.79 Million NOK	-4.13%
2011 Q4	149.62 Million NOK	6.56%
2011 FY	149.62 Million NOK	2.52%
2011 Q1	147.9 Million NOK	1.34%
2011 Q3	140.41 Million NOK	-0.97%
2010 FY	145.94 Million NOK	0.22%
2010 Q3	134.68 Million NOK	2.16%
2010 Q2	131.83 Million NOK	-8.92%
2010 Q1	144.74 Million NOK	-0.61%
2010 Q4	145.94 Million NOK	8.36%
2009 FY	145.62 Million NOK	0.17%
2009 Q4	145.62 Million NOK	0.0%
2008 FY	145.38 Million NOK	12.88%
2007 FY	128.79 Million NOK	8.09%
2006 FY	119.14 Million NOK	40.18%
2005 FY	84.99 Million NOK	14.57%
2004 FY	74.18 Million NOK	0.0%

Peer Total Assets Comparison of Medistim ASA

Name	Total Assets	Total Assets Difference
Gentian Diagnostics ASA	180.58 Million NOK	-180.041%
Lifecare AS	86.38 Million NOK	-485.391%

Global Stocks Search

Medistim ASA (MEDI.OL)

Total Assets Summary of Medistim ASA

Annual Total Assets Chart of Medistim ASA (2023 - 2004)

Historical Annual Total Assets of Medistim ASA (2023 - 2004)

Peer Total Assets Comparison of Medistim ASA